banner-bg banner-bg
dr-shagun-walia

Dr. Shagun Walia

Consultant - Paediatric Endocrinologist

ISPAE Fellowship in Paediatric and Adolescent Endocrinology - Bai Jerbai Wadia Hospital for Children Mumbai, ACLP (Advanced Certified Lactation Professional) BEI, DNB (Paediatrics)- National Board of Examinations New Delhi, MD (Paediatrics) Kasturba Medical College Manipal University, MBBS Government Medical College Patiala.

Book appointment

Select Month

September
October

Select Date

Book Appointment
commo-btn-up-arrow
About Dr. Shagun Walia

Dr. Shagun Walia is a paediatric endocrinologist with over a decade of experience in managing growth, puberty, diabetes, thyroid, adrenal, and metabolic disorders in children. A gold medalist in MBBS, she completed her MD and senior residency from reputed national institutes, followed by a fellowship in paediatric and adolescent endocrinology at Bai Jerbai Wadia Hospital, Mumbai. She has also been part of the cancer survivor endocrine clinics at Tata Memorial Hospital, Mumbai. Dr. Walia has rich clinical experience in evaluating and treating complex endocrine disorders using advanced diagnostic and therapeutic approaches to ensure comprehensive care for children with hormonal conditions.

Specialization And Expertise

Growth and Puberty Disorders (Short stature, Precocious or Delayed Puberty)

Paediatric Diabetes and Obesity

Thyroid and Adrenal Disorders

Bone Health and Metabolic Disorders

Endocrine Late Effects in Cancer Survivors

Endocrine tumours

Ambiguous genitalia, DSD

Publication

Rao S., Walia S. Genetics of Congenital Adrenal Hyperplasia. In Children with Differences in Sex Development: A Multidisciplinary Management Approach. Springer, 2024.

Mehta A., Walia S. et al. Neonatal Severe Hyperparathyroidism: A Single-centre Experience from Western India. IMPE Abstracts. 2023;96

Walia S. et al. Hereditary Hypomagnesaemia with Secondary Hypocalcaemia: A Case Series from India. IMPE Abstracts. 2023;96

Rao C.S. et al., Walia S. Long-acting Octreotide Analogue in Diazoxide-unresponsive Congenital Hyperinsulinism: Short-term Outcome. IMPE Abstracts. 2023;96

×
Back to top
×

Request Call Back



× Disclaimer Image
×

Share Profile Via